NOV
Novo Nordisk A/S
Stock XETRA / Francfort – Stock Market Prices, News & Analysis
Novo Nordisk A/S is a global pharmaceutical company focused on the research, development, and marketing of treatments for diabetes and other serious hormonal diseases.
€ 32.00
0.16 %
Novo Nordisk A/S
€
32.00
0.16 %
NOV
Novo Nordisk A/S is a global pharmaceutical company focused on the research, development, and marketing of treatments for diabetes and other serious hormonal diseases.
NOV
NOV
Anantys Community
Anantys Community
1 member holds Novo Nordisk A/S with an average return of -46.4%. Join them to follow signals and build your long-term investment strategy.
Held by
1 member
Watchlists
0
Avg return
-46.4%
Avg capital
608.0 EUR
Price history of Novo Nordisk A/S
Price history of Novo Nordisk A/S
Performance & Momentum
6 Months
33.46 %
1 Year
54.09 %
3 Years
29.84 %
5 Years
114.53 %
Momentum
79
Similar stocks to Novo Nordisk A/S
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
